On November 9, Marvell Technology rose 3.65% in Regular Trading to $146.94 per share, with turnover of $447 million.

The most relevant recent catalyst in public information is a fresh price-target cut from B. Riley, which lowered its target on Marvell Technology to $250 from $275 while maintaining a Buy rating. That followed earlier debate around Marvell Technology's proposed all-stock acquisition of Lumentum, a transaction valued at about $115 billion, which had pressured the shares on concerns including dilution, regulatory review, customer conflict, and integration risk.

At the same time, recent trading in the stock has also been influenced by broader semiconductor moves. Public reports in recent sessions described Marvell Technology's rebound attempts as closely tied to sector recovery, while options activity showed continued positioning around the $150 level, highlighting that bullish and defensive views remain in conflict even as the stock bounced.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)